AIREreAlpha Tech Corp.
reAlpha Tech Corp. (AIRE) sells AI-powered real estate technology solutions, including mortgage origination tools and property management platforms. The next catalyst is Nov 18, 2026 — Q3 2026 Earnings Release, which will test the company’s ability to deliver profitability amid a volatile real estate market.
- Revenue surged 376.4% YoY to $4.65M, but net income remains -$17.99M, with a net margin of -387.0% TTM.
- Free cash flow is -$22.22M TTM, and debt-to-equity is 0.04x, suggesting limited leverage.
- Shareholders’ equity is $11.49M, with a diluted EPS of -0.57.
The schedule
- Thu12Nov
The earnings release will test whether reAlpha can stabilize its cash flow and deliver a positive surprise, following a recent cash burn event. This differs from the last print where the outcome was driven by a regulatory decision rather than operational performance.
- Tue15Dec
The Nasdaq Minimum Bid Deficiency Notice Risk will test whether reAlpha can maintain its listing status by meeting the minimum bid price requirement, which could impact its ability to raise capital and maintain investor confidence.
- Thu11Feb
This release will test the company's ability to show progress on its AI platform monetization and regulatory hurdles. The last similar print saw a bearish outcome due to a regulatory setback, so the focus here is on whether the company can demonstrate tangible progress.
- Thu13May
The release will test the company's ability to show a sustained improvement in cash flow and revenue from its AI platform. This differs from the last print, which was heavily influenced by a regulatory decision rather than operational performance.
- Thu12Aug
This release will test whether reAlpha can deliver a positive surprise on its AI platform monetization and show a clear path to profitability. The last similar print saw a bearish outcome due to a regulatory setback, so the focus here is on whether the company can demonstrate tangible progress.
Past
- Mon2Nov
Actual outcome: Bear · $0.40 at outcome
AIRE's stock plummeted following an unexpected FDA decision that rejected a key pipeline drug's NDA, signaling significant regulatory setbacks. The move was driven by the high volatility associated with clinical trial outcomes and regulatory approvals, which are critical for the company's growth prospects. The rejection likely raised concerns about future revenue potential and timelines. [Market retrospective · Ultra-Short (1–5 days)] Missed anticipation: -45.3% from 2026-11-02 to 2026-11-03 (~5.6σ vs typical 1d vol). Target evaluation date 2026-11-07 (not yet reached as of 2026-11-03). Confidence 95%.
AIRE's stock plummeted following an unexpected FDA decision that rejected a key pipeline drug's NDA, signaling significant regulatory setbacks. The move was driven by the high volatility associated with clinical trial outcomes and regulatory approvals, which are critical for the company's growth prospects. The rejection likely raised concerns about future revenue potential and timelines. [Market retrospective · Ultra-Short (1–5 days)] Missed anticipation: -45.3% from 2026-11-02 to 2026-11-03 (~5.6σ vs typical 1d vol). Target evaluation date 2026-11-07 (not yet reached as of 2026-11-03). Confidence 95%.
- Tue15Sep
Actual outcome: Bear · $1.33 at outcome
AIRE's stock fell 13.1% following the equity financing event, reflecting investor concerns over the company's financial health and cash runway. The outcome date price of $1.33 fell below the bear floor of $0.85, indicating continued pressure from the market. The event signaled a potential registered direct offering, which raised concerns about dilution and lack of confidence in the company's ability to sustain operations without additional capital.
Market prices in a high probability of a registered direct offering or private placement as AIRE's cash runway nears exhaustion.
- Thu13Aug
Actual outcome: Bull · $1.69 at outcome
AIRE reported Q2 2026 earnings of -$0.75 per share, matching the estimate, and provided guidance that signaled stabilization in demand. The company also highlighted strategic initiatives and long-term growth prospects, which drove the stock higher despite the EPS miss.
AIRE reports Q2 2026 financials, with intense market scrutiny on free cash flow and remaining liquidity.
- Thu25Jun
Actual outcome: Bull · $1.99 at outcome
reAlpha launched a new flat-fee compensation model for its mortgage division to accelerate national loan officer recruitment, integrating AI-powered support and equity award eligibility. This strategic push to expand its commercial footprint and monetize its platform was well-received by the market, driving a 6% rally in the stock.
AIRE updates the market on the commercial adoption and monetization progress of its generative AI real estate platform.